13 articles for thisTarget
The following articles (labelled with PubMed ID or TBD) are for your review
PMID
Cmpds
Data
Article Title
Organization
2
Systematic variation of the benzenesulfonamide part of the GluN2A selective NMDA receptor antagonist TCN-201.
University of M£Nster
12
Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 2.
Nippon Roche Research Center
16
Lipopeptide antifungal agents: Amine conjugates of the semi-synthetic pneumocandins L-731,373 and L-733,560
TBA
21
Antifungal lipopeptides: Structure-activity relationships of 3-hydroxyglutamine-modified pneumocandin B0 derivatives
TBA
12
Synthesis and antifungal activities of novel 1,3-beta-D-glucan synthase inhibitors. Part 1.
Nippon Roche Research Center
23
Positive and Negative Allosteric Modulators of N-Methyl-d-aspartate (NMDA) Receptors: Structure-Activity Relationships and Mechanisms of Action.
University of Bristol
20
SAR studies of pyridazinone derivatives as novel glucan synthase inhibitors.
Merck Research Laboratories
3
Effect of Candida glabrata FKS1 and FKS2 mutations on echinocandin sensitivity and kinetics of 1,3-beta-D-glucan synthase: implication for the existing susceptibility breakpoint.
University of Medicine and Dentistry of New Jersey
3
Caspofungin-resistant Candida tropicalis strains causing breakthrough fungemia in patients at high risk for hematologic malignancies.
University of Medicine and Dentistry of New Jersey
3
A Ser678Pro substitution in Fks1p confers resistance to echinocandin drugs in Aspergillus fumigatus.
Umdnj-New Jersey Medical School
1
Acquired echinocandin resistance in a Candida krusei isolate due to modification of glucan synthase.
Rutgers University
3
Serum differentially alters the antifungal properties of echinocandin drugs.
Public Health Research Institute
7
FUSED BICYCLIC EGFR INHIBITORS AND METHODS OF USE THEREOF
Dana-Farber Cancer Institute